(Q42668250)

4 November 2017

Crystal structures of active SRC kinase domain complexes (English)

1 reference

4 November 2017

1 reference

9

Robert Huber

1 reference

4 November 2017

Christine B Breitenlechner

1

1 reference

4 November 2017

Norman A Kairies

2

1 reference

4 November 2017

Konrad Honold

3

1 reference

4 November 2017

Stefan Scheiblich

4

1 reference

4 November 2017

Hans Koll

5

1 reference

4 November 2017

Eva Greiter

6

1 reference

4 November 2017

Stefan Koch

7

1 reference

4 November 2017

Wolfgang Schäfer

8

1 reference

4 November 2017

Richard A Engh

10

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

Journal of Molecular Biology

4 November 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

4 November 2017

353

1 reference

4 November 2017

2

1 reference

4 November 2017

222-231

1 reference

Substituted 5,7-diphenyl-pyrrolo[2,3d]pyrimidines: potent inhibitors of the tyrosine kinase c-Src

4 November 2017

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Transforming gene product of Rous sarcoma virus phosphorylates tyrosine

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Src in human carcinogenesis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Regulation of protein kinases; controlling activity through activation segment conformation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Refinement of macromolecular structures by the maximum-likelihood method

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

A novel inhibitor of the tyrosine kinase Src suppresses phosphorylation of its major cellular substrates and reduces bone resorption in vitro and in rodent models in vivo

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Crystal structure of the Src family tyrosine kinase Hck

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Leucine 255 of Src couples intramolecular interactions to inhibition of catalysis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Variation on an Src-like theme

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Structural basis for selective inhibition of Src family kinases by PP1

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Src in cancer: deregulation and consequences for cell behaviour

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

The specificities of protein kinase inhibitors: an update

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

A renaissance for SRC

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

The crystal structure of a c-Src complex in an active conformation suggests possible steps in c-Src activation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Activation of pp60c-src protein kinase activity in human colon carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Effects of phosphorylation of threonine 160 on cyclin-dependent kinase 2 structure and activity

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Structural basis for the autoinhibition of c-Abl tyrosine kinase

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Crystal structure of the tyrosine kinase domain of the human insulin receptor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Intramolecular regulatory interactions in the Src family kinase Hck probed by mutagenesis of a conserved tryptophan residue.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Nucleotide sequence of an avian sarcoma virus oncogene (src) and proposed amino acid sequence for gene product

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

The protein kinase activity modulation sites: mechanisms for cellular regulation - targets for therapeutic intervention

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Nucleotide sequence of Rous sarcoma virus

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Domain movements in protein kinases

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Three-dimensional structure of the tyrosine kinase c-Src

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Structures of the cancer-related Aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Cellular effects of purvalanol A: a specific inhibitor of cyclin-dependent kinase activities

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Identifying in vivo targets of cyclin-dependent kinase inhibitors by affinity chromatography

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

pp60c-src activation in human colon carcinoma

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

The protein kinase complement of the human genome

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Crystal structures of c-Src reveal features of its autoinhibitory mechanism

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

The 2.35 A crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Structure and regulation of Src family kinases

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Crystal structure of cyclin-dependent kinase 2

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Structure of the carboxyl-terminal Src kinase, Csk

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JMB.2005.08.023

Identifiers

DOI

10.1016/J.JMB.2005.08.023

1 reference

4 November 2017

1 reference